Gold tier: mechanically validated evidence, with its primary source.
47 evidence items · page 1 / 2
10.8 odds_ratioThe summary odds ratio between non-autoimmune diabetes and SARS-CoV-2 infection risk was 10.8 (95% CI: 10.3–11.4) based on one study.
CamerounCOVID-19 · non-autoimmune diabetes mellituspublished 2021Scientific reportseurope_pmcdocument of 11 observationsDOI 10.1038/s41598-021-88598-6
69 patientsSixty-nine out of 80 COVID-19 positive patients (86.3%) had baseline cortisol ≤413.79 nmol/L, suggesting an insufficient response to stress.
CamerounCOVID-19published 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
The COVID-19 pandemic occurred in 2020.
CamerounCOVID-19observed 2020published 2022Journal of public health in Africaeurope_pmcdocument of 9 observationsDOI 10.4081/jphia.2022.2195
22.2 %The in-hospital mortality among COVID-19 patients hospitalized at Laquintinie Douala hospital in Cameroon was 22.2%.
CamerounCOVID-19observed 2020published 2022Travel medicine and infectious diseaseeurope_pmcdocument of 5 observations
18.6 %Overall age-standardized SARS-CoV-2 IgG seroprevalence in Yaoundé, Cameroon was 18.6% during January 27–February 6, 2021.
CamerounCOVID-19observed January 27–February 6, 2021published 2022Emerging infectious diseasesOpenAlexdocument of 2 observationsDOI 10.3201/eid2806.212580
75 bpmA reduction of heart rate was observed between D0 and D7 (75±13 bpm versus 70±13 bpm, p = 0.02).
CamerounCOVID-19observed 2020published 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument of 6 observationsDOI 10.1101/2020.06.24.20139386
51.3 %Overall age-standardized SARS-CoV-2 IgG seroprevalence in Yaoundé, Cameroon was 51.3% during April 24–May 19, 2021.
CamerounCOVID-19observed April 24–May 19, 2021published 2022Emerging infectious diseasesOpenAlexdocument of 2 observationsDOI 10.3201/eid2806.212580
No symptomatic arrhythmic events occurred during the treatment course.
CamerounCOVID-19observed 2020published 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument of 6 observationsDOI 10.1101/2020.06.24.20139386
429 msNo significant change from baseline (D0) of QTc was observed at D7 (429±27 ms at D0 versus 396±26 ms at D7; p=0.27).
CamerounCOVID-19observed 2020published 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument of 6 observationsDOI 10.1101/2020.06.24.20139386
5 %PCR-positivity was 5% at IUEs/INSAM-Yaounde.
CamerounCOVID-19observed November 2020 to July 2021published 2023VirusesOpenAlexdocument of 12 observationsDOI 10.3390/v15020407
25.25 %PCR-positivity was 25.25% at UdM-Bangangte, 27.27% at ISSBA-Yaounde, and 5% at IUEs/INSAM-Yaounde.
CamerounCOVID-19observed November 2020 to July 2021published 2023VirusesOpenAlexdocument of 12 observationsDOI 10.3390/v15020407
7 casesAmong the 80 COVID-19 positive patients, diabetes mellitus was present in 7 (8.8%).
CamerounCOVID-19 · diabète (non précisé)published 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
80.4 %At day 3, 74 out of 92 participants (80.4%) on doxycycline were asymptomatic.
CamerounCOVID-19published 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument of 8 observationsDOI 10.1101/2021.07.25.21260838
9 casesAmong the 80 COVID-19 positive patients, hypertension was present in 9 (11.3%), diabetes mellitus in 7 (8.8%), cardiovascular disease in 8 (10%), and obesity in 4 (5%).
CamerounCOVID-19 · hypertension artériellepublished 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
65.2 %On day 10, 60 out of 92 participants (65.2%) assigned to doxycycline had a negative SARS-CoV-2 PCR test.
CamerounCOVID-19published 2023Cureuseurope_pmcdocument of 7 observations
27.27 %PCR-positivity was 27.27% at ISSBA-Yaounde.
CamerounCOVID-19observed November 2020 to July 2021published 2023VirusesOpenAlexdocument of 12 observationsDOI 10.3390/v15020407
75 casesAmong the 80 COVID-19 positive patients, respiratory symptoms were reported in 75 (93.7%).
CamerounCOVID-19published 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
95.7 %On day 10, 88 out of 92 participants (95.7%) on doxycycline were asymptomatic.
CamerounCOVID-19published 2023Cureuseurope_pmcdocument of 7 observations
95 msQRS duration increased between D0 and D7 (95±10 ms versus 102±17 ms, p = 0.004).
CamerounCOVID-19observed 2020published 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument of 6 observationsDOI 10.1101/2020.06.24.20139386
4 casesAmong the 80 COVID-19 positive patients, obesity was present in 4 (5%).
CamerounCOVID-19 · obésitépublished 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
At day 30, all participants were asymptomatic.
CamerounCOVID-19published 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument of 8 observationsDOI 10.1101/2021.07.25.21260838
10 patientsAmong the 80 COVID-19 positive patients, 10 (12.5%) received oxygen therapy.
CamerounCOVID-19published 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
70 casesAmong the 80 COVID-19 positive patients, the non-severe form was the most common, observed in 70 (87.5%).
CamerounCOVID-19published 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
97.9 %At day 10, 93 out of 95 participants (97.9%) on hydroxychloroquine-azithromycin were asymptomatic.
CamerounCOVID-19published 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument of 8 observationsDOI 10.1101/2021.07.25.21260838
On day 30, all participants were asymptomatic.
CamerounCOVID-19published 2023Cureuseurope_pmcdocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.